Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BELLMUNT J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 32 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bellmunt, J; de Wit, R; Albanell, J; Baselga, J
      A feasibility study of carboplatin with fixed dose of gemcitabine in 'unfit' patients with advanced bladder cancer

      EUROPEAN JOURNAL OF CANCER
    2. Bellmunt, J; Guillem, V; Paz-Ares, L; Gonzalez-Larriba, JL; Carles, J; Albanell, J; Tabernero, JM; Cortes-Funes, H; Baselga, J
      Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer

      EUROPEAN JOURNAL OF CANCER
    3. Cos, J; Bellmunt, J; Soler, C; Ribas, A; Lluis, JM; Murio, JE; Margarit, C
      Comparative study of sequential combinations of paclitaxel and methotrexate on a human bladder cancer cell line

      CANCER INVESTIGATION
    4. Bellmunt, J; Guillem, V; Paz-Ares, L; Gonzalez-Larriba, JL; Carles, J; Batiste-Alentorn, E; Saenz, A; Lopez-Brea, M; Font, A; Nogue, M; Bastus, R; Climent, MA; de la Cruz, JJ; Albanell, J; Banus, JM; Gallardo, E; Diaz-Rubio, E; Cortes-Funes, H; Baselga, J
      Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium

      JOURNAL OF CLINICAL ONCOLOGY
    5. BUESA JM; LOPEZPOUSA A; MARTIN J; ANTON A; DELMURO JG; BELLMUNT J; ARRANZ F; VALENTI V; ESCUDERO P; MENENDEZ D; CASADO A; POVEDA A
      PHASE-II TRIAL OF FIRST-LINE HIGH-DOSE IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS OF THE ADULT - A STUDY OF THE SPANISH GROUP FOR RESEARCHON SARCOMAS (GEIS)

      Annals of oncology
    6. CARLES J; BASTUS R; BROTO J; NOGUE M; TABERNERO J; SALAZAR R; ARCUSA A; DOMENECH M; BELLMUNT J; GARCIA A; ROMERO J; TRESCA P
      PHASE-II STUDY OF VINORELBINE AND ESTRAMUSTINE PHOSPHATE IN HORMONE-RESISTANT CARCINOMA OF THE PROSTATE (HRPC) PRELIMINARY-RESULTS

      Annals of oncology
    7. CARULLA J; BELLMUNT J; SANZ X; SANCHEZ JM; URDAMBIDELUS A; GIRALT J; DELCAMPO JM; BODI R; SOLECALVO LA
      2ND LINE CHEMOTHERAPY BASED IN VINORELBINE AND ORAL FLUOPIRIMIDINES IN RELAPSING HEAD AND NECK-CANCER - A PILOT-STUDY - OUTCOME AND SYMPTOMCONTROL

      Annals of oncology
    8. DOMBERNOWSKY P; SMITH I; FALKSON G; LEONARD R; PANASCI L; BELLMUNT J; BEZWODA W; GARDIN G; GUDGEON A; MORGAN M; FORNASIERO A; HOFFMANN W; MICHEL J; HATSCHEK T; TJABBES T; CHAUDRI HA; HORNBERGER U; TRUNET PF
      LETROZOLE, A NEW ORAL AROMATASE INHIBITOR FOR ADVANCED BREAST-CANCER - DOUBLE-BLIND RANDOMIZED TRIAL SHOWING A DOSE-EFFECT AND IMPROVED EFFICACY AND TOLERABILITY COMPARED WITH MEGESTROL-ACETATE

      Journal of clinical oncology
    9. MOLINA R; SEGUI MA; CLIMENT MA; BELLMUNT J; ALBANELLI J; FERNANDEZ M; FILELLA X; JO J; GIMENEZ N; IGLESIAS E; MIRALLES M; ALONSO C; PEIRO G; PEREZPICANOL E; BALLESTA AM
      P53 ONCOPROTEIN AS A PROGNOSTIC INDICATOR IN PATIENTS WITH BREAST-CANCER

      Anticancer research
    10. ERES N; BELLMUNT J
      REGULATORY PROTEINS OF THE CELL-CYCLE - ALTERATIONS IN THE CYCLIN C1 ROUTE AS A PARADIGM - FINDINGS IN BREAST-CANCER

      Medicina Clinica
    11. RIBAS A; ALBANELL J; SOLECALVO LA; GALLARDO E; BELLMUNT J; VERA R; VIDAL R; CARULLA J; BASELGA J
      CYCLOPHOSPHAMIDE, METHOTREXATE, AND CHRONIC ORAL TEGAFUR MODULATED BYFOLINIC ACID IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CARCINOMA

      Cancer
    12. RIBAS A; ALBANELL J; BELLMUNT J; BERMEJO B; GALLARDO E; VERA R; BODI R; SOLECALVO LA
      FREQUENT DOSE DELAYS AND GROWTH-FACTOR REQUIREMENTS WITH THE SEQUENTIAL DOXORUBICIN-CMF SCHEDULE

      Acta oncologica
    13. SALUD A; PORCEL JM; VIDALPLA R; BELLMUNT J
      PULMONARY METASTATIZING BENIGN LEIOMYOMA EVOLVING TO CHRONIC RESPIRATORY-FAILURE

      Medicina Clinica
    14. BELLMUNT J; RIBAS A; ERES N; ALBANELL J; ALMANZA C; BERMEJO B; SOLE LA; BASELGA J
      CARBOPLATIN-BASED VERSUS CISPLATIN-BASED CHEMOTHERAPY IN THE TREATMENT OF SURGICALLY INCURABLE ADVANCED BLADDER-CARCINOMA

      Cancer
    15. RIBAS A; ALBANELL J; BELLMUNT J; SOLECALVO LA
      ADVERSE EFFECT ON BONE-MARROW PROTECTION OF PRECHEMOTHERAPY GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT

      Journal of the National Cancer Institute
    16. RIBAS A; ALBANELL J; BELLMUNT J; SOLECALVO LA; BERMEJO B; GALLARDO E; VIDAL R; VERA R; ERES N; CARULLA J; BASELGA J
      5-DAY COURSE OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH PROLONGED NEUTROPENIA AFTER ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER IS A SAFE AND COST-EFFECTIVE SCHEDULE TO MAINTAIN DOSE-INTENSITY

      Journal of clinical oncology
    17. RIBAS A; BELLMUNT J; ALBANELL J; DETORRES I; BERMEJO B; DETORRES JA; MOROTE J; GALLARDO E; VERA R; CARULLA J; SOLECALVO LA
      EARLY RESULTS OF THE VALUE OF P53 IN PREDICTING SURVIVAL IN A HOMOGENEOUS COHORT OF PATIENTS WITH INVASIVE BLADDER-CANCER TREATED WITH A NEOADJUVANT CARBOPLATIN-BASED REGIMEN (M-CAVI)

      Tumori
    18. BELLMUNT J; RIBAS A; ALBANELL J; BERMEJO B; VERA R; DETORRES JA; MOROTE J; LOPEZPACIOS MA; MANUS JM; ROVIROSA A; CARULLA J; SOLE LA
      M-CAVI, A NEOADJUVANT CARBOPLATIN-BASED REGIMEN FOR THE TREATMENT OF T2-4NOMO CARCINOMA OF THE BLADDER

      American journal of clinical oncology
    19. ERES N; BELLMUNT J
      THE CLINICAL IMPORTANCE OF THE FIBROBLAST GROWTH-FACTOR AS A BIOLOGICAL MARKER AND THERAPEUTIC MODULATOR - FUTURE APPLICATIONS

      Medicina Clinica
    20. SALUD A; PORCEL JM; ROVIROSA A; BELLMUNT J
      ENDOBRONCHIAL METASTATIC DISEASE - ANALYSIS OF 32 CASES

      Journal of surgical oncology
    21. BELLMUNT J; RIBAS A; CASADO S; ALBANELL J; CARULLA J; SOLE LA
      HIGH-DOSE CONTINUOUS-INFUSION (CI) IFOSFAMIDE WITHOUT HEMATOPOIETIC SUPPORT IN HEAVILY PRETREATED BREAST-CANCER (BC) AND SARCOMA (S) PATIENTS

      European journal of cancer
    22. VICENTE P; BELLMUNT J; ARMADANS L; DETORRES I; JOLIS L
      MULTIDRUG-RESISTANCE IN BLADDER-CANCER - ROLE OF P-GLYCOPROTEIN IN THE RESPONSE TO CHEMOTHERAPY

      European journal of cancer
    23. RIBAS A; FAKHRAI H; SHAWLER D; SOBOL R; BELLMUNT J; SOLE LA
      TRANSDUCTION AND SELECTION OF MURINE TUMOR-CELLS ENGINEERED TO EXPRESS THE INTERLEUKIN-2 (IL-2) AND HERPES-SIMPLEX VIRUS THYMIDINE KINASE (HSVTK) GENES

      European journal of cancer
    24. RIBAS A; BELLMUNT J; ALBANELL J; CAPDEVILA JA; OCANA I; GALLEGO OS; MALDONADO J; GIRALT J; SOLE LA
      MALIGNANT LYMPHOPROLIFERATIVE-DISEASES IN HIV-SEROPOSITIVE PATIENTS -A STUDY OF 40 CASES AT A SINGLE INSTITUTION IN SPAIN

      Acta oncologica
    25. RIBAS A; BELLMUNT J; SOLE LA; RIBASMUNDO M
      CORTICOID TREATMENT IN CASTLEMANS DISEASE

      Medicina Clinica
    26. SOLE LA; ALBANELL J; BELLMUNT J; RIBAS A; GALLEGO OS; CARULLA J
      PHASE-II TRIAL OF AN ALL-ORAL REGIMEN OF TEGAFUR AND FOLINIC ACID IN PATIENTS WITH PREVIOUSLY TREATED METASTATIC BREAST-CANCER

      Cancer
    27. GALLEGOMELCON S; DETOLEDO JS; DOSTE D; LOPEZ D; MORAGA F; RODRIGUEZ C; VIDAL T; BELLMUNT J
      LATE RECURRENT METASTASIS IN WILMS-TUMOR

      Medical and pediatric oncology
    28. RIBAS A; BELLMUNT J
      GENIC THERAPY - NEW PERSPECTIVES IN THE T REATMENT OF CANCER

      Medicina Clinica
    29. VILA A; BELLMUNT J; RILO A; SABALLS P
      BILATERAL CHOROIDEAL METASTASIS AS A FORM OF PRESENTATION OF PULMONARY-CARCINOMA

      Medicina Clinica
    30. ROVIROSA A; BELLMUNT J; LOPEZ A; FERNANDEZ M; GUERRA M; MONTAGUT J
      THE INCIDENCE OF 2ND NEOPLASMS IN ADVANCE D LARYNGEAL-CANCER - IMPACTON SURVIVAL

      Medicina Clinica
    31. VICENTE P; BELLMUNT J; RUIZMARCELLAN C; GARCIA A; ROVIROSA A; SOLE LA
      PRIMARY NON-HODGKINS-LYMPHOMA OF THE BREA ST

      Medicina Clinica
    32. VICENTE P; BELLMUNT J; DETORRES I
      GLYCOPROTEIN-P AND RESISTENCE TO ANTITUMORAL CHEMOTHERAPY

      Medicina Clinica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 18:47:19